
REVIVA PHARMACEUTICALS HOLDINGS, INC.
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
WebsitePrice
Market cap
Next catalystFDA formulation-strategy feedback expected in Q4 2026brilaroxazine — planned RECOVER-2 · Regulatory meetingSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved